Skip to main content
Log in

The clinical significance of memory T cells and its subsets in gastric cancer

  • Research Article
  • Published:
Clinical and Translational Oncology Aims and scope Submit manuscript

Abstract

Background

Long life of memory T cell (Tm) determines its crucial role in the carcinogenesis and carcinogenic progression which usually take long time. The Tm compartment contains two populations, central memory T cells (Tcm) and effector memory T cells (Tem), based on their phenotypic markers, functional attributes, and migratory properties.

Methods

We investigated the subsets of the Tm in peripheral blood and tumor microenvironments in patients with gastric cancer by flow cytometry, and aimed to explore the correlation between the Tm and clinicopathologic features of gastric cancer.

Results

The percentages of CD4+/CD8+ Tm and CD4+/CD8+ Tcm in peripheral blood from gastric cancer patients were statistically lower, whereas the percentages of CD4+/CD8+ Tem were significantly higher than healthy controls. The proportion of CD4+/CD8+ Tcm increased after tumor resection, while the percentage of the CD4+/CD8+ Tem decreased significantly. Significant associations were detected between the peripheral CD4+/CD8+ Tm and clinical stage, as well as the CD8+ Tcm and clinical stage and nodal involvement. Tumor infiltrating CD8+ Tm expressed both central and effector memory phenotypes, whereas CD4+ Tm displayed predominantly an effector memory phenotype. Higher percentages of tumor infiltrating CD4+/CD8+ Tm were significantly associated with the early disease stage.

Conclusions

Tm and its subsets were good immune indicators for the disease stage of gastric cancer. The proportion of Tm subsets may reflect the immune suppressive and immune response to the tumor associated antigen.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Sallusto F, Lenig D, Forster R, Lipp M, Lanzavecchia A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature. 1999;401(6754):708–12.

    Article  CAS  PubMed  Google Scholar 

  2. Manjunath N, Shankar P, Wan J, Weninger W, Crowley MA, Hieshima K, et al. Effector differentiation is not prerequisite for generation of memory cytotoxic T lymphocytes. J Clin Invest. 2001;108(6):871–8.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  3. Wherry EJ, Teichgraber V, Becker TC, Masopust D, Kaech SM, Antia R, et al. Lineage relationship and protective immunity of memory CD8 T cell subsets. Nat Immunol. 2003;4(3):225–34.

    Article  CAS  PubMed  Google Scholar 

  4. Klebanoff CA, Gattinoni L, Torabi-Parizi P, Kerstann K, Cardones AR, Finkelstein SE, et al. Central memory self/tumor-reactive CD8+ T cells confer superior antitumor immunity compared with effector memory T cells. Proc Natl Acad Sci USA. 2005;102(27):9571–6.

    Article  CAS  PubMed  Google Scholar 

  5. Klebanoff CA, Gattinoni L, Restifo NP. CD8+ T-cell memory in tumor immunology and immunotherapy. Immunol Rev. 2006;211:214–24.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  6. Lalvani A, Brookes R, Hambleton S, Britton WJ, Hill AV, McMichael AJ. Rapid effector function in CD8+ memory T cells. J Exp Med. 1997;186(6):859–65.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  7. Novy P, Quigley M, Huang X, Yang Y. CD4 T cells are required for CD8 T cell survival during both primary and memory recall responses. J Immunol. 2007;179(12):8243–51.

    CAS  PubMed  Google Scholar 

  8. Hwang ML, Lukens JR, Bullock TN. Cognate memory CD4+ T cells generated with dendritic cell priming influence the expansion, trafficking, and differentiation of secondary CD8+ T cells and enhance tumor control. J Immunol. 2007;179(9):5829–38.

    CAS  PubMed  Google Scholar 

  9. Merkenschlager M, Terry L, Edwards R, Beverley PC. Limiting dilution analysis of proliferative responses in human lymphocyte populations defined by the monoclonal antibody UCHL1: implications for differential CD45 expression in T cell memory formation. Eur J Immunol. 1988;18(11):1653–61.

    Article  CAS  PubMed  Google Scholar 

  10. Hotta K, Sho M, Fujimoto K, Shimada K, Yamato I, Anai S, et al. Prognostic significance of CD45RO+ memory T cells in renal cell carcinoma. Br J Cancer. 2011;105(8):1191–6.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  11. Xiang R, Lode HN, Gillies SD, Reisfeld RA. T cell memory against colon carcinoma is long-lived in the absence of antigen. J Immunol. 1999;163(7):3676–83.

    CAS  PubMed  Google Scholar 

  12. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69–90.

    Article  PubMed  Google Scholar 

  13. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55(2):74–108.

    Article  PubMed  Google Scholar 

  14. Belov L, Zhou J, Christopherson RI. Cell surface markers in colorectal cancer prognosis. Int J Mol Sci. 2010;12(1):78–113.

    Article  PubMed Central  PubMed  Google Scholar 

  15. Pages F, Galon J, Dieu-Nosjean MC, Tartour E, Sautes-Fridman C, Fridman WH. Immune infiltration in human tumors: a prognostic factor that should not be ignored. Oncogene. 2010;29(8):1093–102.

    Article  CAS  PubMed  Google Scholar 

  16. Mlecnik B, Tosolini M, Charoentong P, Kirilovsky A, Bindea G, Berger A, et al. Biomolecular network reconstruction identifies T-cell homing factors associated with survival in colorectal cancer. Gastroenterology. 2010;138(4):1429–40.

    Article  CAS  PubMed  Google Scholar 

  17. Bindea G, Mlecnik B, Fridman WH, Galon J. The prognostic impact of anti-cancer immune response: a novel classification of cancer patients. Semin Immunopathol. 2011;33(4):335–40.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  18. Hara M, Matsuzaki Y, Shimizu T, Tomita M, Ayabe T, Enomoto Y, et al. Preoperative peripheral naive/memory ratio and prognosis of nonsmall-cell lung cancer patients. Ann Thorac Cardiovasc Surg. 2007;13(6):384–90.

    PubMed  Google Scholar 

  19. Kuss I, Schaefer C, Godfrey TE, Ferris RL, Harris JM, Gooding W, et al. Recent thymic emigrants and subsets of naive and memory T cells in the circulation of patients with head and neck cancer. Clin Immunol. 2005;116(1):27–36.

    Article  PubMed  Google Scholar 

  20. Sallusto F, Lanzavecchia A. Exploring pathways for memory T cell generation. J Clin Invest. 2001;108(6):805–6.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  21. Barbieri C, Fujisawa MM, Yasuda CL, Metze IL, Oliveira EC, Santos LM, et al. Effect of surgical treatment on the cellular immune response of gastric cancer patients. Braz J Med Biol Res. 2003;36(3):339–45.

    Article  CAS  PubMed  Google Scholar 

  22. Tanel A, Fonseca SG, Yassine-Diab B, Bordi R, Zeidan J, Shi Y, et al. Cellular and molecular mechanisms of memory T-cell survival. Expert Rev Vaccin. 2009;8(3):299–312.

    Article  CAS  Google Scholar 

  23. Kaech SM, Wherry EJ, Ahmed R. Effector and memory T-cell differentiation: implications for vaccine development. Nat Rev Immunol. 2002;2(4):251–62.

    Article  CAS  PubMed  Google Scholar 

  24. Rauser S, Langer R, Tschernitz S, Gais P, Jutting U, Feith M, et al. High number of CD45RO+ tumor infiltrating lymphocytes is an independent prognostic factor in non-metastasized (stage I–IIA) esophageal adenocarcinoma. BMC Cancer. 2010;10:608.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  25. Pages F, Berger A, Camus M, Sanchez-Cabo F, Costes A, Molidor R, et al. Effector memory T cells, early metastasis, and survival in colorectal cancer. N Engl J Med. 2005;353(25):2654–66.

    Article  CAS  PubMed  Google Scholar 

  26. Broussard EK, Disis ML. TNM staging in colorectal cancer: T is for T cell and M is for memory. J Clin Oncol. 2011;29(6):601–3.

    Article  PubMed  Google Scholar 

  27. Nosho K, Baba Y, Tanaka N, Shima K, Hayashi M, Meyerhardt JA, et al. Tumour-infiltrating T-cell subsets, molecular changes in colorectal cancer, and prognosis: cohort study and literature review. J Pathol. 2010;222(4):350–66.

    Article  PubMed Central  PubMed  Google Scholar 

  28. Lee HE, Chae SW, Lee YJ, Kim MA, Lee HS, Lee BL, et al. Prognostic implications of type and density of tumour-infiltrating lymphocytes in gastric cancer. Br J Cancer. 2008;99(10):1704–11.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

Download references

Acknowledgments

This work was supported partially by the Tianjin Natural Science Funds (no. 13JCYBJC24200 and 13JCQNJC12700).

Conflict of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to X. Ren.

Additional information

R. Zhang and F. Li contributed equally.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zhang, R., Li, F., Li, H. et al. The clinical significance of memory T cells and its subsets in gastric cancer. Clin Transl Oncol 16, 257–265 (2014). https://doi.org/10.1007/s12094-013-1066-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12094-013-1066-5

Keywords

Navigation